Technology Offers Page 3

Yissum - Research Development Company of the Hebrew University posted this:

Differential Production of Cannabinoids CBD and THC Cluster11 Project ID : 8-2017-4417

Yissum - Research Development Company of the Hebrew University posted this:

Pro-Nano Lipospheres as Oral Delivery Platform for Lipophilic Drugs Cluster9 oral dispersible concentrate preparation for improving the bioavailability and distribution of lipidic drugs that are substrates of first pass intestinal metabolism and/or are substrates of Pgp efflux. Thus, the formulation elevates the amount of drug that reach the systemic blood circulation and reduces the variability in the oral absorption properties. Project ID : 6-2008-2126

Pro-Nano Lipospheres as Oral Delivery Platform for Lipophilic Drugs

Yissum - Research Development Company of the Hebrew University posted this:

New CNS-Active Carbamate Derivatives for Epilepsy New CNS-active carbamate derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide with a broad potent antiepileptic activity Project ID : 6-2017-4419

New CNS-Active Carbamate Derivatives for Epilepsy

Yissum - Research Development Company of the Hebrew University posted this:

Nano-Particles for Intranasal Delivery of Biodegradable Neuropeptide Cluster9 Project ID : 6-2014-3054

Nano-Particles for Intranasal Delivery of Biodegradable Neuropeptide

Yissum - Research Development Company of the Hebrew University posted this:

Small Molecules Antagonists Of Toll Like Receptor 9 For Treatment Of Inflammatory Conditions Toll-like receptors, receptors of the innate immunity, play a critical role in the development of many pathological states, in acute and chronic inflammatory processes. Therefore, TLRs represent a new direction for immunotherapy. In order to discover novel ligands interacting with TLRs, Iterative Stochastic Elimination, an innovative beyond-state-of the-art in Silico method for predicting the chances of molecular bioactivity were employed (HUJI IDR). The most promising drug candidates were verified by a cell-based test-system (Fraunhofer IGB) that allows TLR antagonists/agonist to be identified in a reporter gene assay. The ISE process in addition with the assay lead to novel immune modulating therapeutics Project ID : 6-2015-3128

Small Molecules Antagonists Of Toll Like Receptor 9 For Treatment Of Inflammatory Conditions

Yissum - Research Development Company of the Hebrew University posted this:

Quantum Nano Materials for Photo-Catalytic Applications Composition of metal-semiconductor nanoparticles for the generation of reactive species (radicals, peroxides) in solution. This project covers different embodiments that have other researchers involved on different subsets (therapeutics, photoinitiators). For example, there is a biological aspect, whereby a biological assay is a result of a pathway started with reactive species generation. Project ID : 9-2015-3191

Quantum Nano Materials for Photo-Catalytic Applications

Yissum - Research Development Company of the Hebrew University posted this:

Oral Delivery Platform for Lipophilic Drugs Based on Pro-Nano Lipospheres Cluster9 Dispersible Concentrate Lipospheres for the Delivery of Agents (PNL) Project ID : 6-2017-4492

Oral Delivery Platform for Lipophilic Drugs Based on Pro-Nano Lipospheres

Yissum - Research Development Company of the Hebrew University posted this:

Nanoparticle Sensor for RDX and Other Nitroamine-Based Explosives Nanoparticles matrix for the detection of non-planar and non-aromatic nitroamine analytes. Keywords: explosive detection, RDX, nitroamines, nanosensor, Devices, Molecular Electronics, Nano Materials and Nano Structures, Soil, Pollutant Detection, Homeland Security Homeland Security Project ID : 9-2010-2364

Nanoparticle Sensor for RDX and Other Nitroamine-Based Explosives

Yissum - Research Development Company of the Hebrew University posted this:

Personalizing Risk Assessment and Treatment Decisions in Cancers Cluster8 A unified method for the diagnosis and treatment of cancer based on the Expression of the Cancer Tetis Antigen gene Family in Individuals. CTA genes are very active during cellular differentiation and growth and non-active otherwise. The biopsy is beeing tested. Big database. Project ID : 19-2016-4283

Yissum - Research Development Company of the Hebrew University posted this:

Sustainable Pesticide Combination to Control Pathogens in Agriculture Cluster11 Green multi-hurdle pesticides to control pathogeens in agriculture Project ID : 8-2016-4271

Yissum - Research Development Company of the Hebrew University posted this:

Small Molecules for Treatment of Diabetes by Induction of Cellular Senescence ENHANCEMENT OF GLUCOSE-STIMULATED INSULIN SECRETION BY CELLS THROUGH INDUCTION OF CELLULAR SENESCENCE Project ID : 6-2016-4284

Small Molecules for Treatment of Diabetes by Induction of Cellular Senescence

Yissum - Research Development Company of the Hebrew University posted this:

Repurposing of an Approved Drug to Increase NKp30 Ligands for Cancer Immunotherapy THE USE OF “INTEGRATED STRESS RESPONSE” ACTIVATORS FOR ENHANCING B7H6-TRAGETED TREATMENTS Project ID : 6-2018-4573

Yissum - Research Development Company of the Hebrew University posted this:

Cyber Security for Group Messaging via Out-of-Band Authentication Cluster4 Cluster6 Project ID : 10-2018-4574

Cyber Security for Group Messaging via Out-of-Band Authentication

Yissum - Research Development Company of the Hebrew University posted this:

A Method for Generating Herbicide Resistant Plants "herbicide encapsulation by ligand binding proteins to induce herbicide-resistant in crops" Project ID : 21-2016-4387

Yissum - Research Development Company of the Hebrew University posted this:

Targeted Drug Delivery by Cathepsin Nanofiber Substrates Cluster8 Cluster9 Cathepsin Nanofiber Substrates as Potential Agent for Targeted Drug Delivery Project ID : 6-2017-4395

Targeted Drug Delivery by Cathepsin Nanofiber Substrates

1
2
3
4
5